AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell & Gene Hub

New technology and capacity help CDMO’s advanced-therapies campus meet growing market demand

SEATTLE, May 17, 2022, a leading global Biopharmaceutical Contract Development and Manufacturing Organizationin Longmont, Col., USA. These new…